Clinical Trial Results:
A Phase I/II, Single Center, Partially Observer-Blind, Controlled, Randomized Study to Explore Safety and Immunogenicity in Healthy Adult Subjects who Receive Either One Dose of Chiron Combined MenC-Hib Conjugate Vaccine, OR Separate Administration of Chiron Hib Conjugate Vaccine (VaxemHib) and Chiron MenC Conjugate Vaccine (Menjugate), OR One Dose of Menjugate, OR One Dose of VaxemHib
Summary
|
|
EudraCT number |
2004-000767-10 |
Trial protocol |
IT |
Global completion date |
10 Nov 2004
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
06 Mar 2016
|
First version publication date |
06 Mar 2016
|
Other versions |
|
Summary report(s) |
V82P1_CTRD |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.